Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.

CD4+CD25+Foxp3+ Tregs have an indispensable role in the maintenance of tolerance after allogeneic HSC transplantation (HSCT). Patients with chronic graft-versus-host disease (GVHD) have fewer circulating Tregs, but the mechanisms that lead to this deficiency of Tregs after HSCT are not known. Here, we analyzed reconstitution of Tregs and conventional CD4+ T cells (Tcons) in patients who underwent allogeneic HSCT after myeloablative conditioning. Following transplant, thymic generation of naive Tregs was markedly impaired, and reconstituting Tregs had a predominantly activated/memory phenotype. In response to CD4+ lymphopenia after HSCT, Tregs underwent higher levels of proliferation than Tcons, but Tregs undergoing homeostatic proliferation also showed increased susceptibility to Fas-mediated apoptosis. Prospective monitoring of CD4+ T cell subsets revealed that Tregs rapidly expanded and achieved normal levels by 9 months after HSCT, but Treg levels subsequently declined in patients with prolonged CD4+ lymphopenia. This resulted in a relative deficiency of Tregs, which was associated with a high incidence of extensive chronic GVHD. These studies indicate that CD4+ lymphopenia is a critical factor in Treg homeostasis and that prolonged imbalance of Treg homeostasis after HSCT can result in loss of tolerance and significant clinical disease manifestations.

[1]  S. Riddell,et al.  Safety and immunologic effects of IL-15 administration in nonhuman primates. , 2009, Blood.

[2]  H. Jim,et al.  Quality of life after allogeneic hematopoietic cell transplantation. , 2009, Blood.

[3]  P. Bouillet,et al.  CD95, BIM and T cell homeostasis , 2009, Nature Reviews Immunology.

[4]  T. Nomura,et al.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. , 2009, Immunity.

[5]  G. Labbadia,et al.  PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. , 2009, The Journal of clinical investigation.

[6]  J. Ritz,et al.  Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  L. Hennighausen,et al.  Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells , 2009, Nature Immunology.

[8]  A. Thiel,et al.  Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. , 2009, Blood.

[9]  J. Sprent,et al.  Generation and maintenance of memory CD4(+) T Cells. , 2001, Current opinion in immunology.

[10]  J. Sprent,et al.  Homeostasis of naive and memory T cells. , 2008, Immunity.

[11]  N. Taylor,et al.  Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions , 2008, Proceedings of the National Academy of Sciences.

[12]  Christopher G. King,et al.  Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation. , 2008, Blood.

[13]  D. Venzon,et al.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets , 2008, The Journal of experimental medicine.

[14]  A. Khoruts,et al.  Regulatory CD4+CD25+Foxp3+ T Cells Selectively Inhibit the Spontaneous Form of Lymphopenia-Induced Proliferation of Naive T Cells1 , 2008, The Journal of Immunology.

[15]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[16]  E. Bonifacio,et al.  Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. , 2008, The Journal of clinical investigation.

[17]  J. Phair,et al.  Homeostasis of the Naive CD4+ T Cell Compartment during Aging1 , 2008, The Journal of Immunology.

[18]  T. Yi,et al.  In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. , 2007, Blood.

[19]  A. Nademanee,et al.  Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. , 2007, Blood.

[20]  R. Gress,et al.  T cell immune reconstitution following lymphodepletion. , 2007, Seminars in immunology.

[21]  P. Rossini,et al.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.

[22]  P. Krammer,et al.  Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis1 , 2007, The Journal of Immunology.

[23]  A. Rot,et al.  CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells , 2007, The Journal of experimental medicine.

[24]  Helen Y Wang,et al.  Regulatory T cells and cancer. , 2007, Current opinion in immunology.

[25]  F. Dazzi,et al.  T-cell receptor repertoire usage after allografting differs between CD4+CD25+ regulatory T cells and their CD4+CD25- counterpart. , 2007, Haematologica.

[26]  R. Andreesen,et al.  Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. , 2006, Blood.

[27]  R. Geffers,et al.  Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. , 2006, Blood.

[28]  A. Akbar,et al.  Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo , 2006 .

[29]  J. Ritz,et al.  IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. , 2006, Blood.

[30]  L. Turka,et al.  PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. , 2006, The Journal of clinical investigation.

[31]  Chang H. Kim Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system. , 2006, Experimental hematology.

[32]  T. Fry,et al.  Autoimmunity during lymphopenia: a two-hit model. , 2006, Clinical immunology.

[33]  Shimon Sakaguchi,et al.  Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.

[34]  W. Selby,et al.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.

[35]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[36]  Clare Baecher-Allan,et al.  MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells1 , 2006, The Journal of Immunology.

[37]  S. Rosenberg,et al.  IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. , 2006, Blood.

[38]  B. Grubeck‐Loebenstein,et al.  Imbalance of regulatory T cells in human autoimmune diseases , 2006, Immunology.

[39]  E. Thiel,et al.  Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. , 2006, Blood.

[40]  M. A. Curotto de Lafaille,et al.  Control of homeostatic proliferation by regulatory T cells. , 2005, The Journal of clinical investigation.

[41]  A. Rudensky,et al.  A function for interleukin 2 in Foxp3-expressing regulatory T cells , 2005, Nature Immunology.

[42]  W. Blackwelder,et al.  Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer , 2005, Nature Medicine.

[43]  J. Berzofsky,et al.  Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells , 2005, Nature Medicine.

[44]  J. Ritz,et al.  Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. , 2005, Blood.

[45]  R. Budd,et al.  The Death Receptor Fas (CD95/APO-1) Mediates the Deletion of T Lymphocytes Undergoing Homeostatic Proliferation1 , 2005, The Journal of Immunology.

[46]  M. Pierer,et al.  Post‐thymic in vivo proliferation of naive CD4+ T cells constrains the TCR repertoire in healthy human adults , 2005, European journal of immunology.

[47]  R. V. van Lier,et al.  Cutting Edge: CD95 Maintains Effector T Cell Homeostasis in Chronic Immune Activation , 2005, The Journal of Immunology.

[48]  J. Lohr,et al.  T‐cell tolerance and autoimmunity to systemic and tissue‐restricted self‐antigens , 2005, Immunological reviews.

[49]  Shimon Sakaguchi,et al.  Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization , 2005, The Journal of experimental medicine.

[50]  E. Graviss,et al.  Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy , 2005, AIDS.

[51]  Matthias Edinger,et al.  Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. , 2005, Blood.

[52]  A. Khoruts,et al.  A causal link between lymphopenia and autoimmunity , 2004, Immunology Letters.

[53]  J. Serody,et al.  L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. , 2004, Blood.

[54]  H. Takada,et al.  CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. , 2004, Experimental hematology.

[55]  N. Sarvetnick,et al.  Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity , 2004, Cell.

[56]  M. Flowers,et al.  Chronic graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[57]  J. Markmann,et al.  Homeostatic proliferation is a barrier to transplantation tolerance , 2004, Nature Medicine.

[58]  D. Klatzmann,et al.  Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. , 2003, The Journal of clinical investigation.

[59]  M. V. D. van den Brink,et al.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. , 2003, The Journal of clinical investigation.

[60]  C. Fathman,et al.  CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation , 2003, Nature Medicine.

[61]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[62]  Y. Shoenfeld,et al.  HIV and autoimmunity. , 2002, Autoimmunity reviews.

[63]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[64]  B. Blazar,et al.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. , 2002, Blood.

[65]  Andreas Radbruch,et al.  Two Subsets of Naive T Helper Cells with Distinct T Cell Receptor Excision Circle Content in Human Adult Peripheral Blood , 2002, The Journal of experimental medicine.

[66]  D. Klatzmann,et al.  Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice. , 2001, Blood.

[67]  H. Lazarus,et al.  Chronic graft-versus-host disease: clinical manifestation and therapy , 2001, Bone Marrow Transplantation.

[68]  L. Bogatzki,et al.  Naive T Cells Transiently Acquire a Memory-like Phenotype during Homeostasis-Driven Proliferation , 2000, The Journal of experimental medicine.

[69]  Jianzhu Chen,et al.  Homeostasis-Stimulated Proliferation Drives Naive T Cells to Differentiate Directly into Memory T Cells , 2000, The Journal of experimental medicine.

[70]  R. Ahmed,et al.  Cutting Edge: Naive T Cells Masquerading as Memory Cells , 2000, The Journal of Immunology.

[71]  E. Bonifacio,et al.  Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. , 2000, Diabetes.

[72]  S. Jameson,et al.  Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  B. Charpentier,et al.  Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles. , 1999, Blood.

[74]  Å. Lernmark,et al.  Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. , 1999, Diabetes.

[75]  C. Mackall,et al.  T-cell regeneration: all repertoires are not created equal. , 1997, Immunology today.

[76]  P. Gleeson,et al.  Organ‐specific Autoimmunity Induced by Lymphopenia , 1996, Immunological reviews.

[77]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[78]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.